Overview

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

Phase II Study of Avastin Plus Rituximab for Patients with Relapsed and Chemotherapy - or Rituxan Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Genentech, Inc.

Treatments:

Bevacizumab
Rituximab